| [1] |
CAIANO LM, RIVA N, CARRIER M, et al. Treatment of portal vein thrombosis: An updated narrative review[J]. Minerva Med, 2021, 112( 6): 713- 725. DOI: 10.23736/S0026-4806.21.07526-1.
|
| [2] |
CUSTO S, TABONE E, AQUILINA A, et al. Splanchnic vein thrombosis: The state-of-the-art on anticoagulant treatment[J]. Hamostaseologie, 2024, 44( 4): 242- 254. DOI: 10.1055/a-2232-5480.
|
| [3] |
TONG WL, GADANI S. Chronic portal vein thrombosis: Diagnosis, management, and review of the literature[J]. Tech Vasc Interv Radiol, 2025, 28( 4): 101084. DOI: 10.1016/j.tvir.2025.101084.
|
| [4] |
CHEN HS, TRILOK G, WANG F, et al. A single hospital study on portal vein thrombosis in cirrhotic patients- clinical characteristics& risk factors[J]. Indian J Med Res, 2014, 139( 2): 260- 266.
|
| [5] |
ODRIOZOLA A, PUENTE Á, CUADRADO A, et al. Portal vein thrombosis in the setting of cirrhosis: A comprehensive review[J]. J Clin Med, 2022, 11( 21): 6435. DOI: 10.3390/jcm11216435.
|
| [6] |
HUANG XY, ZHANG YH, YI SY, et al. Potential contribution of the gut microbiota to the development of portal vein thrombosis in liver cirrhosis[J]. Front Microbiol, 2023, 14: 1217338. DOI: 10.3389/fmicb.2023.1217338.
|
| [7] |
SENZOLO M, GARCIA-TSAO G, GARCÍA-PAGÁN JC. Current knowledge and management of portal vein thrombosis in cirrhosis[J]. J Hepatol, 2021, 75( 2): 442- 453. DOI: 10.1016/j.jhep.2021.04.029.
|
| [8] |
ANTON A, CAMPRECIÓS G, PÉREZ-CAMPUZANO V, et al. The pathophysiology of portal vein thrombosis in cirrhosis: Getting deeper into Virchow's triad[J]. J Clin Med, 2022, 11( 3): 800. DOI: 10.3390/jcm11030800.
|
| [9] |
WU JL, DENG XY, LUO JY, et al. Update in the treatment of cirrhotic patients with portal vein thrombosis[J]. Clin Mol Hepatol, 2025, 31( 4): 1139- 1166. DOI: 10.3350/cmh.2025.0411.
|
| [10] |
LIN YK, CAI XR, HONG HJ, et al. Risk factors of portal vein system thrombosis after splenectomy: A meta-analysis[J]. ANZ J Surg, 2023, 93( 12): 2806- 2819. DOI: 10.1111/ans.18633.
|
| [11] |
MANTAKA A, GATSELIS N, TRIANTOS CK, et al. Treatment of portal vein thrombosis in cirrhosis: A multicenter real life cohort study[J]. Minerva Gastroenterol, 2023, 69( 1): 107- 113. DOI: 10.23736/s2724-5985.21.02861-8.
|
| [12] |
de VLOO C, MATTON T, MEERSSEMAN W, et al. Thrombosis of a portal vein aneurysm: A case report with literature review[J]. Acta Clin Belg, 2019, 74( 2): 115- 120. DOI: 10.1080/17843286.2018.1511298.
|
| [13] |
GERA DN, PATEL J, PATEL K, et al. Portal vein thrombosis: A rare complication of nephrotic syndrome[J]. Indian J Nephrol, 2018, 28( 3): 236- 239. DOI: 10.4103/ijn.IJN_25_17.
|
| [14] |
CAO L, WEI K, HAI J, et al. Efficacy and safety of different antithrombotic regimens including direct oral anticoagulants for the prevention of portal vein system thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension: A systematic review and network meta-analysis[J]. Int J Surg, 2025, 111( 12): 9706- 9725. DOI: 10.1097/JS9.0000000000003220.
|
| [15] |
TURON F, DRIEVER EG, BAIGES A, et al. Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors[J]. J Hepatol, 2021, 75( 6): 1367- 1376. DOI: 10.1016/j.jhep.2021.07.020.
|
| [16] |
PONZIANI FR, ZOCCO MA, CAMPANALE C, et al. Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatment[J]. World J Gastroenterol, 2010, 16( 2): 143- 155. DOI: 10.3748/wjg.v16.i2.143.
|
| [17] |
UEDA T, SAITO H, SHIRAI S, et al. Endovascular treatment for acute portal vein thrombosis[J]. Interv Radiol, 2024, 10: e20230027. DOI: 10.22575/interventionalradiology.2023-0027.
|
| [18] |
YERDEL MA, GUNSON B, MIRZA D, et al. Portal vein thrombosis in adults undergoing liver transplantation: Risk factors, screening, management, and outcome[J]. Transplantation, 2000, 69( 9): 1873- 1881. DOI: 10.1097/00007890-200005150-00023.
|
| [19] |
de FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno VII-Renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76( 4): 959- 974. DOI: 10.1016/j.jhep.2021.12.022.
|
| [20] |
Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis(2020,Shanghai)[J]. J Clin Hepatol, 2020, 36( 12): 2667- 2674. DOI: 10.3969/j.issn.1001-5256.2020.12.007.
中华医学会消化病学分会肝胆疾病学组. 肝硬化门静脉血栓管理专家共识(2020年,上海)[J]. 临床肝胆病杂志, 2020, 36( 12): 2667- 2674. DOI: 10.3969/j.issn.1001-5256.2020.12.007.
|
| [21] |
MOLVAR C, AMIN P. Portal vein thrombosis in cirrhosis: Interventional treatment options[J]. Curr Gastroenterol Rep, 2021, 23( 12): 24. DOI: 10.1007/s11894-021-00826-1.
|
| [22] |
GIRARDI L, ZARKA F, PRADIER M, et al. Diagnostic performance of ultrasound, computed tomography and magnetic resonance imaging in portal vein thrombosis: A systematic review with meta-analysis[J]. Thromb Res, 2026, 257: 109560. DOI: 10.1016/j.thromres.2025.109560.
|
| [23] |
JU C, LI X, GADANI S, et al. Portal vein thrombosis: Diagnosis and endovascular management[J]. Rofo, 2022, 194( 2): 169- 180. DOI: 10.1055/a-1642-0990.
|
| [24] |
ZHOU L, HUANG ZC, LIN XH, et al. Case report: CT manifestations of acute portal vein thrombosis: Cases report and literature review[J]. Front Radiol, 2025, 5: 1662089. DOI: 10.3389/fradi.2025.1662089.
|
| [25] |
COPIN P, RONOT M, NUZZO A, et al. Inter-reader agreement of CT features of acute mesenteric ischemia[J]. Eur J Radiol, 2018, 105: 87- 95. DOI: 10.1016/j.ejrad.2018.05.027.
|
| [26] |
PLESSIER A, DARWISH-MURAD S, HERNANDEZ-GUERRA M, et al. Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study[J]. Hepatology, 2010, 51( 1): 210- 218. DOI: 10.1002/hep.23259.
|
| [27] |
van DAM LF, KLOK FA, TUSHUIZEN ME, et al. Magnetic resonance thrombus imaging to differentiate acute from chronic portal vein thrombosis[J]. TH Open, 2020, 4( 3): e224- e230. DOI: 10.1055/s-0040-1716716.
|
| [28] |
LI CM, HU A, HAACKE M, et al. Direct portal vein thrombosis visualization with t2*-weighted magnetic resonance imaging[J]. Int J Med Sci, 2013, 10( 11): 1570- 1574. DOI: 10.7150/ijms.6681.
|
| [29] |
JOSHI A, KULKARNI S, SHAH A. Role of MRI in evaluation of spectrum of liver lesions in cirrhotic patients[J]. J Assoc Physicians India, 2020, 68( 4): 32- 38.
|
| [30] |
WANG SK, CHENG YF, LIM WX, et al. Applying intraoperative portal venography in liver transplantation vascular surgery[J]. Diagnostics, 2025, 15( 18): 2321. DOI: 10.3390/diagnostics15182321.
|
| [31] |
DEBERNARDI-VENON W, BANDI JC, GARCÍA-PAGÁN JC, et al. CO2 wedged hepatic venography in the evaluation of portal hypertension[J]. Gut, 2000, 46( 6): 856- 860. DOI: 10.1136/gut.46.6.856.
|
| [32] |
YANG L, BETTMANN MA. Identification of the portal vein: Wedge hepatic venography with CO2 or iodinated contrast medium[J]. Acad Radiol, 1999, 6( 2): 89- 93. DOI: 10.1016/S1076-6332(99)80487-5.
|
| [33] |
CAPOROSSI JM, VIDAL V, JACQUIER A, et al. Balloon occlusion versus wedged hepatic venography using iodinated contrast for targeting the portal vein during TIPS[J]. Diagn Interv Imaging, 2015, 96( 4): 357- 363. DOI: 10.1016/j.diii.2014.11.011.
|
| [34] |
de FRANCHIS R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63( 3): 743- 752. DOI: 10.1016/j.jhep.2015.05.022.
|
| [35] |
DELGADO MG, SEIJO S, YEPES I, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis[J]. Clin Gastroenterol Hepatol, 2012, 10( 7): 776- 783. DOI: 10.1016/j.cgh.2012.01.012.
|
| [36] |
European Association for the Study of the Liver. EASL clinical practice guidelines on vascular diseases of the liver[J]. J Hepatol, 2026, 84( 2): 399- 456. DOI: 10.1016/j.jhep.2025.08.001.
|
| [37] |
TSOCHATZIS EA, SENZOLO M, GERMANI G, et al. Systematic review: Portal vein thrombosis in cirrhosis[J]. Aliment Pharmacol Ther, 2010, 31( 3): 366- 374. DOI: 10.1111/j.1365-2036.2009.04182.x.
|
| [38] |
XIAO XL, ZHU WG, DAI QX. Direct oral anticoagulants versus traditional anticoagulation in cirrhotic patients with portal vein thrombosis: Updated systematic review[J]. Clin Appl Thromb Hemost, 2024, 30: 10760296241303758. DOI: 10.1177/10760296241303758.
|
| [39] |
ELKRIEF L, HERNANDEZ-GEA V, SENZOLO M, et al. Portal vein thrombosis: Diagnosis, management, and endpoints for future clinical studies[J]. Lancet Gastroenterol Hepatol, 2024, 9( 9): 859- 883. DOI: 10.1016/S2468-1253(24)00155-9.
|
| [40] |
KUMARI D. Acute mesenteric and portal vein thrombosis: Etiology, diagnosis, and interventional management[J]. Tech Vasc Interv Radiol, 2025, 28( 3): 101058. DOI: 10.1016/j.tvir.2025.101058.
|
| [41] |
PRIMIGNANI M, TOSETTI G, IERARDI AM. Approach to different thrombolysis techniques and timing of thrombolysis in the management of portal vein thrombosis in cirrhotic patients[J]. J Transl Int Med, 2023, 11( 3): 198- 202. DOI: 10.2478/jtim-2023-0113.
|
| [42] |
HOLLINGSHEAD M, BURKE CT, MAURO MA, et al. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis[J]. J Vasc Interv Radiol, 2005, 16( 5): 651- 661. DOI: 10.1097/01.RVI.0000156265.79960.86.
|
| [43] |
LIU FY, WANG MQ, DUAN F, et al. Interventional therapy for symptomatic-benign portal vein occlusion[J]. Hepatogastroenterology, 2010, 57( 104): 1367- 1374.
|
| [44] |
ALANI M, ROWLEY M, KANG P, et al. Utility of transjugular intrahepatic portosystemic shunt placement for maintaining portal vein patency in candidates on wait lists who develop thrombus[J]. Exp Clin Transplant, 2020, 18( 7): 808- 813. DOI: 10.6002/ect.2019.0153.
|
| [45] |
RAVAIOLI M, ZANELLO M, GRAZI GL, et al. Portal vein thrombosis and liver transplantation: Evolution during 10 years of experience at the University of Bologna[J]. Ann Surg, 2011, 253( 2): 378- 384. DOI: 10.1097/SLA.0b013e318206818b.
|